• Corpus ID: 6228179

Biochemical markers in acute ischemic stroke.

@article{Hill2000BiochemicalMI,
  title={Biochemical markers in acute ischemic stroke.},
  author={Michael D. Hill and George Jackowski and N. Bayer and Matthew J Lawrence and Roman Jaeschke},
  journal={CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne},
  year={2000},
  volume={162 8},
  pages={
          1139-40
        }
}
  • M. Hill, G. Jackowski, R. Jaeschke
  • Published 18 April 2000
  • Medicine, Psychology
  • CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne
The diagnosis of ischemic stroke remains a clinical one, with confirmatory evidence obtained through neuroimaging. Early ischemic changes may be subtle or absent on CT scans. Analogous to the role that the creatine kinase (CK) MB fraction or troponin testing plays in the management of acute coronary 

Tables from this paper

Blood Biomarkers in the Diagnosis of Ischemic Stroke: A Systematic Review
TLDR
There are limitations in the design and reporting of all the studies that mean no biomarker can be recommended for use in clinical practice, and recommendations are made for the design or reporting of studies of diagnostic blood biomarkers in stroke.
Blood Biomarkers in the Diagnosis of Ischemic Stroke
TLDR
There are limitations in the design and reporting of all the studies that mean no biomarker can be recommended for use in clinical practice, and recommendations are made for the design or reporting of studies of diagnostic blood biomarkers in stroke.
Clinical application of blood biomarkers in cerebrovascular disease
TLDR
Serum biomarkers related to pathways of hemostasis, oxidation and inflammation, or alterations in glial and neuronal proteins, have been identified but none have been recommended for routine clinical use.
What kind of stroke is it?
  • M. Hill
  • Medicine, Psychology
    Clinical chemistry
  • 2008
TLDR
The search for protein biomarkers in peripheral blood to aid in the diagnosis of stroke and the prediction of prognosis after stroke and risk of future stroke is an active area of investigation but no biochemical markers have proven to be really useful in routine clinical practice.
Blood Biomarkers of Ischemic Stroke
TLDR
Though many candidate blood based biomarkers for ischemic stroke have been identified, none are currently used in clinical practice and with further well designed study and careful validation, the development of blood biomarkers to improve the care of patients with isChemic stroke may be achieved.
Stroke biomarkers: progress and challenges for diagnosis, prognosis, differentiation, and treatment.
TLDR
This work discusses the current classification, diagnosis, and treatment of stroke, focusing on use of novel biomarkers (either solitary markers or multiple markers within a panel) that have been studied in a variety of clinical settings.
BIOMARKER ADVANCES IN ACUTE ISCHEMIC STROKE
TLDR
Recent advances in biomarker discovery may provide an invaluable tool in the evaluation of patients with potential stroke, and with current interventions for ischemic stroke being extremely time dependent, the burden of stroke diagnosis rests squarely on the shoulders of Emergency Medicine physicians.
Association of Serial Biochemical Markers With Acute Ischemic Stroke: The National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study
TLDR
This study corroborates previous work demonstrating correlations of MBP, NSE, and S100&bgr; with clinical and radiographic features in acute stroke, and finds no difference in the early release of the 4 biomarkers between treatment groups.
Blood markers for the diagnosis and prognosis of stroke
TLDR
This thesis aims to provide a history of web exceptionalism from 1989 to 2002, a period chosen in order to explore its roots as well as specific cases up to and including the year in which descriptions of “Web 2.0” began to circulate.
ASSOCIATION BETWEEN ENOLASE SERUM LEVELS AND OUTCOME ACUTE ISCHEMIC STROKE ONE MONTH AFTER ONSET SPECIFIC
TLDR
Based on the study results, NSE levels were associated with damage to the brain parenchyma and could assess the outcome of stroke one-month later.
...
...

References

SHOWING 1-7 OF 7 REFERENCES
Serum S-100 Protein, Relationship to Clinical Outcome in Acute Stroke
TLDR
Measurement of serum S-100 protein could be a useful prognostic marker of clinical outcome in acute stroke and whether S- 100 concentrations can be altered by therapeutic intervention in acute strokes remains to be elucidated.
Rapid and sensitive immunoassay for the measurement of serum S100B using isoform-specific monoclonal antibody.
TLDR
This work has developed an ELISA that is rapid, highly sensitive, and S100B specific and was used to retrospectively assess S 100B concentrations in the serum of stroke patients.
S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction.
TLDR
The S-100 concentrations in serum were significantly higher in patients with severe neurological deficits at admission, with extensive infarctions and a space-occupying effect of ischemic edema as compared with the rest of the population.
Determination of S‐100 and Glial Fibrillary Acidic Protein Concentrations in Cerebrospinal Fluid After Brain Infarction
TLDR
It is suggested that determinations of cerebrospinal fluid astroglial protein concentrations can be used to estimate ischemic brain damage, which should be of particular value in clinical trials of pharmacological agents, such as calcium antagonists, on stroke patients.